All Stories

  1. Ventilatory Response to Hypercapnia as Experimental Model to Study Effects of Oxycodone on Respiratory Depression

    Article • Current Reviews in Clinical and Experimental Pharmacology, March 2022, Bentham Science Publishers

    Dr Lynn Webster

  2. The association of pain interference and opioid use with healthcare utilization and costs, and wage loss among adults with osteoarthritis in the United States

    Article • Journal of Medical Economics, September 2019, Taylor & Francis

    Dr Lynn Webster, Drishti Shah

  3. Real-world misuse, abuse, and dependence of abuse-deterrent versus non-abuse-deterrent extended-release morphine in Medicaid non-cancer patients

    Article • Postgraduate Medicine, March 2019, Taylor & Francis

    Sidney Schnoll, Dr Lynn Webster, Michael Polson

  4. Extended-release morphine sulfate and naltrexone hydrochloride (EMBEDA): naltrexone-associated withdrawal and abuse-related effects in patients with chronic pain and recreational opioid users

    Article • Current Medical Research and Opinion, November 2018, Taylor & Francis

    Dr Lynn Webster

  5. Oral methylnaltrexone is efficacious and well tolerated for the treatment of opioid-induced constipation in patients with chronic noncancer pain receiving concomitant methadone

    Article • Journal of Pain Research, October 2018, Dove Medical Press

    Dr Lynn Webster

  6. Oral methylnaltrexone does not negatively impact analgesia in patients with opioid-induced constipation and chronic noncancer pain

    Article • Journal of Pain Research, August 2018, Dove Medical Press

    Dr Lynn Webster

  7. Analysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain [Corrigendum]

    Article • Journal of Pain Research, June 2018, Dove Medical Press

    Dr Lynn Webster

  8. Intranasal Pharmacokinetics of Morphine ARER, a Novel Abuse-Deterrent Formulation: Results from a Randomized, Double-Blind, Four-Way Crossover Study in Nondependent, Opioid-Experienced Subjects

    Article • Pain Research and Management, January 2018, Hindawi Publishing Corporation

    Dr Lynn Webster

  9. Opioid-induced constipation: rationale for the role of norbuprenorphine in buprenorphine-treated individuals

    Article • Substance Abuse and Rehabilitation, June 2016, Dove Medical Press

    Dr Lynn Webster

  10. Low-dose naloxone provides an abuse-deterrent effect to buprenorphine

    Article • Journal of Pain Research, November 2015, Dove Medical Press

    Dr Lynn Webster

  11. Analysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain

    Article • Journal of Pain Research, October 2015, Dove Medical Press

    Dr Lynn Webster

  12. The health insurance industry: perpetuating the opioid crisis through policies of cost-containment and profitability

    Article • Journal of Pain Research, March 2015, Dove Medical Press

    Dr Michael E. Schatman, Dr Lynn Webster

  13. Randomized, double-blind, placebo-controlled and active-controlled study to assess the relative abuse potential of oxycodone HCl-niacin tablets compared with oxycodone alone in nondependent, recreational opioid users

    Article • Substance Abuse and Rehabilitation, August 2012, Taylor & Francis

    Dr Lynn Webster

  14. Tolerability of NGX-4010, a capsaicin 8% patch, in conjunction with three topical anesthetic formulations for the treatment of neuropathic pain

    Article • Journal of Pain Research, January 2012, Taylor & Francis

    Dr Lynn Webster

  15. Effectiveness and safety of morphine sulfate extended-release capsules in patients with chronic, moderate-to-severe pain in a primary care setting

    Article • Journal of Pain Research, November 2011, Taylor & Francis

    Dr Lynn Webster

  16. Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic pain

    Article • Journal of Pain Research, November 2011, Taylor & Francis

    Ms Kristine Majors, Dr Lynn Webster

  17. The Role of the Health Insurance Industry in Perpetuating Suboptimal Pain Management

    Article • Pain Medicine, March 2011, Oxford University Press (OUP)

    Dr Lynn Webster

  18. Health Insurance

    Article • Springer Science + Business Media

    Dr Lynn Webster